Metsera, along with Maze Therapeutics, gave U.S. health care first-time share sales its best month since October.

Shares of weight-loss drug developer Metsera surged nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture Partners-backed biotech firm at $2.68 billion. Shares of the company opened ...

The company launched the IPO after doubling revenue in 2024, driven by increased oil production from well acquisitions worth ...

The Company has added an Australian entity, Max Brazil, to hold the "Florália DSO Project" through the existing Canadian and Brazilian holding entities. As announced on January 9, 2025, Max Brazil ...

The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.

Business-to-business seafood startup Captain Fresh on Friday said it has raised Rs 250 crore in its ongoing pre-IPO funding round with participation from both existing and new investors, including ...

Captain Fresh, a B2B seafood startup, secures Rs 250 crore in pre-IPO funding, led by existing investors and prominent family offices. The funding will bolster its balance sheet and pave the way for ...

Q4 2024 Earnings Call Transcript January 30, 2025 Operator: Thank you for standing by. My name is Kate, and I will be your ...

Sources privy to the development said that the company is actively streamlining its operations to address various challenges ...

(Alliance News) - The struggling public market in London got a small, but much-needed, vote of confidence on Friday, as Cardiogeni PLC started trading on Aquis Stock Exchange, while RC Fornax PLC ...

MicroStrategy sold 7.3 million shares of 8% Series A perpetual strike preferred stock to raise $563.4 million, which the ...

The White House press secretary said the president would move forward with levies on America’s largest trading partners on ...